CBLB502
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CBLB502, covering 2017-02-09 to 2017-02-09. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of Safety and Tolerability of CBLB502 as a Neo-adjuvant Treatment in Patients With Colorectal Cancer [Phase 2]